Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2019 - 2026)

Amphastar Pharmaceuticals' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $761000.0 for Q1 2026.

• In Q1 2026, Amortization of Deferred Charges changed 0.13% year-over-year to $761000.0; the TTM figure through Mar 2026 stood at $2.6 million (up 5.67% YoY), while the FY2025 annual figure was $3.4 million, down 44.38% from the prior year.
• Amortization of Deferred Charges was $761000.0 for Q1 2026 at Amphastar Pharmaceuticals, down from $866000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $5.2 million in Q3 2023 to a low of $30000.0 in Q4 2022.
• Historically, Amortization of Deferred Charges has averaged $1.2 million across 5 years, with a median of $612000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges soared 9610.0% in 2023, then plunged 90.45% in 2024.
• A 5-year view of Amortization of Deferred Charges shows it stood at $30000.0 in 2022, then jumped by 9610.0% to $2.9 million in 2023, then plunged by 75.15% to $724000.0 in 2024, then rose by 19.61% to $866000.0 in 2025, then retreated by 12.12% to $761000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $761000.0 (Q1 2026), $866000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.